traitements

Dominique Costagliola is Deputy Director of the Pierre-Louis Institute of Epidemiology and Public Health (Sorbonne University, Inserm). Member of the French Academy of Sciences, she is a member of the scientific board of the REACTing consortium. She gives an update on Covid-19 therapies still in the pipeline. The results of the studies that have been conducted

The names of these promising drugs to treat COVID-19 patients are beginning to become known to the public: Remdesivir, Ritonavir, Lopinavir and of course the most talked about, Chloroquine. These four promising treatments will be the subject of a major global study by the World Health Organization.

How many deaths will the coronavirus cause? No one is yet able to answer this question, but in the worst-case scenario, it could number in the millions around the world, warn experts, who therefore stress the importance of measures such as containment. Time is running out in the face of a

Le coronavirus nous met face à un grave problème. Cependant, il faut se souvenir que l’une des premières victimes du coronavirus aura été l’économie. S’il est important de rendre compte de l’évolution de la situation, il faut également mettre l’accent sur les informations positives. Et elles existent aussi : voici dix

The coronavirus of Chinese origin is spreading, triggering epidemics in many countries at the same time, and now threatens to spread around the world like a full-blown pandemic. All the governments of the states in which patients have been identified are announcing that the spread is inevitable and that it is